TABLE 3.
Clinical differences from the comparison of KTRs who developed cancer (CA+) and KTRs without cancer diagnosis (CA-).
| Clinical variables | CA- (n = 753) | CA+ (n = 177) | p-value | |
|---|---|---|---|---|
| Sex - n (%) | Male patients Female patients |
426 (79.3%) 327 (83.2%) |
111 (20.7%) 66 (16.8%) |
0.08 |
| Transplant donor - n (%) | Deceased Living |
620 (79.9%) 131 (86.2%) |
156 (20.1%) 21 (13.8%) |
0.04 |
| Age at KTx - years | 47.5 ± 13 | 54.6 ± 10.6 | <0.001 | |
| Dialysis type - n (%) | HD PD No |
522 (80.6%) 139 (76.8%) 68 (87.2%) |
125 (19.4%) 42 (23.2%) 10 (12.8%) |
0.17 |
| Dialysis vintage - months | 51.2 ± 49 | 57.8 ± 57.1 | 0.06 | |
| Diabetes pre-KTx - n (%) | Yes No |
44 (81.5%) 684 (80.5%) |
10 (18.5%) 166 (19.5%) |
0.51 |
| History of HCV infection - n (%) | Yes No |
26 (70.3%) 422 (74.7%) |
11 (29.7%) 143 (25.3%) |
0.33 |
| Steroids pre-KTx - n (%) | Yes No |
269 (81%) 417 (80.8%) |
63 (19%) 99 (19.2%) |
0.50 |
| Causes of ESRD – n (%) | CN GN HUS ADPKD Vasculitis PN/NI Other Undetermined |
145 (79.7%) 154 (80.6%) 16 (94.1%) 118 (73.3%) 23 (67.6%) 91 (86.7%) 107 (84.9%) 99 (86.8%) |
37 (20.3%) 37 (19.4%) 1 (5.9%) 43 (26.7%) 11 (32.4%) 14 (13.3%) 19 (15.1%) 15 (13.2%) |
0.011 |
HD, hemodialysis; PD, peritoneal dialysis; CN, chronic nephropathy; GN, glomerulonephritis; HUS, hemolytic uremic syndrome; ADPDK, autosomal dominant polycystic kidney disease; PN/NI, pyelonephritis and interstitial nephritis.
Bold value indicates the statistic significance (p < 0.05).